Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Accord Pharma to Buy the Rest of Shenzhen Sinopharm TCM

publication date: Aug 18, 2010
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

Shenzhen Accord Pharmaceutical will gain full control of Shenzhen Sinopharm Traditional Chinese Medicine by buying the 52.6% stake it doesn’t already own. At 27 million RMB ($4 million), the acquisition is a relatively small one. Accord is buying the stake from industry giant Sinopharm. More details....

Stock Symbols: (SHEX: 000028) (SHEX: 01099)




Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
ChinaBio® Events
CBPF2016
Suzhou, China
May 18 - 19, 2016
Record attendance of 1008!
See us next year in Shunde!

>> More events...

Other Events
Hong Kong, China
June 15–17, 2016
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors